Article info
PDFClinical and epidemiological research
Extended report
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
- Correspondence to Marco Matucci-Cerinic, AOUC Department of Biomedicine, Division of Rheumatology, DENOTHE Center, University of Florence, Villa Monna Tessa, Viale Pieraccini 18, 50139 Florence, Italy; cerinic{at}unifi.it
Citation
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
Publication history
- Accepted July 4, 2010
- First published August 30, 2010.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl